Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.

DOI:10.1016/S1473-3099(22)00435-2
作者：Fang-Hui Zhao,?Ting Wu,?Yue-Mei Hu,?Li-Hui Wei,?Ming-Qiang Li,?Wei-Jin Huang,?Wen Chen,?Shou-Jie Huang,?Qin-Jing Pan,?Xun Zhang,?Ying Hong,?Chao Zhao,?Qing Li,?Kai Chu,?Yun-Fei Jiang,?Ming-Zhu Li,?Jie
文献类型：期刊论文
补充材料：只需要正文